Skip to main content
Archives of Emergency Medicine logoLink to Archives of Emergency Medicine
. 1984 Dec;1(4):197–203. doi: 10.1136/emj.1.4.197

Mild analgesics and the accident and emergency department--cost and safety more important than potency?

D W Yates, G S Laing, K Peters, K Kumar
PMCID: PMC1285227  PMID: 6399444

Abstract

A prospective controlled trial involving over 1000 patients did not reveal any difference between four drugs commonly used in accident and emergency departments for the relief of mild to moderate pain. There were no significant variations in therapeutic effect, side-effects or patient compliance. When considering the supply of analgesics which may be no more potent than those available without prescription from retail chemists, cost and safety are more important than analgesic effect. By restricting the choice of analgesics available, the accident and emergency department should be able to increase awareness among its staff of the actions and side-effects of a small number of prescribed drugs and to contain costs.

Full text

PDF
197

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berbatis C. G., Maher M. J., Plumridge R. J., Stoelwinder J. U., Zubrick S. R. Impact of a drug bulletin on prescribing oral analgesics in a teaching hospital. Am J Hosp Pharm. 1982 Jan;39(1):98–100. [PubMed] [Google Scholar]
  2. Evans P. J., McQuay H. J., Rolfe M., O'Sullivan G., Bullingham R. E., Moore R. A. Zomepirac, placebo and paracetamol/dextropropoxyphene combination compared in orthopaedic postoperative pain. Br J Anaesth. 1982 Sep;54(9):927–933. doi: 10.1093/bja/54.9.927. [DOI] [PubMed] [Google Scholar]
  3. Johnstone E. C., Ferrier I. N. Neuroendocrine markers of CNS drug effects. Br J Clin Pharmacol. 1980 Jul;10(1):5–21. doi: 10.1111/j.1365-2125.1980.tb00497.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Johnstone E. C., Ferrier I. N. Neuroendocrine markers of CNS drug effects. Br J Clin Pharmacol. 1980 Jul;10(1):5–21. doi: 10.1111/j.1365-2125.1980.tb00497.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Johnstone E. C., Ferrier I. N. Neuroendocrine markers of CNS drug effects. Br J Clin Pharmacol. 1980 Jul;10(1):5–21. doi: 10.1111/j.1365-2125.1980.tb00497.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Johnstone E. C., Ferrier I. N. Neuroendocrine markers of CNS drug effects. Br J Clin Pharmacol. 1980 Jul;10(1):5–21. doi: 10.1111/j.1365-2125.1980.tb00497.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Shenfield G. M., Jones A. N., Paterson J. W. Effect of restrictions on prescribing patterns for dextropropoxyphene. Br Med J. 1980 Sep 6;281(6241):651–653. doi: 10.1136/bmj.281.6241.651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Sleet R. A., Khan M. A. Comparative study of mefenamic acid and dextropropoxyphene plus paracetamol in an accident and emergency department. Curr Med Res Opin. 1980;7(2):77–84. doi: 10.1185/03007998009112030. [DOI] [PubMed] [Google Scholar]
  9. Stableforth P. G. Mefenamic acid and dextropropoxyphene with paracetamol as analgesics in the accident department. Curr Med Res Opin. 1977;5(2):189–191. doi: 10.1185/03007997709110163. [DOI] [PubMed] [Google Scholar]
  10. Vaidya A. B., Sheth M. S., Manghani K. K., Shroff P., Vora K. K., Sheth U. K. Double blind trial of mefenamic acid, aspirin and placebo in patients with post-operative pain. Indian J Med Sci. 1974 Dec;28(12):532–536. [PubMed] [Google Scholar]
  11. Winnem B., Samstad B., Breivik H. Paracetamol, tiaramide and placebo for pain relief after orthopedic surgery. Acta Anaesthesiol Scand. 1981 Jun;25(3):209–214. doi: 10.1111/j.1399-6576.1981.tb01638.x. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Emergency Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES